Newsletter Subscription

Tuesday, Dec 6, 2016

Engility Wins $31 M to Support Program Evaluations for the Defense Centers of Excellence

  • Engility to Continue Evaluating Psychological Health and Traumatic Brain Injury Programs

Engility Holdings, Inc. (NYSE: EGL ), today announced it has been awarded a $31 million contract extension to help enhance the effectiveness of psychological health (PH) and Traumatic Brain Injury (TBI) programs that provide care to service members, veterans and their families.

The contract was awarded by the U.S. Army Medical Research Acquisition Activity (USAMRAA) for the Defense Centers of Excellence (DCoE) for PH and TBI. Engility will provide technical assistance to support DCoE's program improvement efforts, which are focused on establishing, prioritizing, assessing and documenting results related to DOD PH and TBI programs. Engility will also implement and maintain a comprehensive, standardized infrastructure for systematic, evidence-based evaluation activities.

Related Research on
Global Biometric Systems Market Research Report 2016

"Engility is honored to support DCoE and the important work it is performing on behalf of this nation's veterans, service members and their families," said Engility President and CEO Tony Smeraglinolo . "The men and women of Engility who are supporting this mission are passionate about DCoE's work to devise sustainable solutions that will help make a lasting impact on the care available to our military and their families."

This 3-year extension was awarded under the TRICARE Evaluation, Analysis and Management Support (TEAMS) IDIQ and is a cost plus fixed fee contract.

Source : Engility Holdings, Inc. - view original press release

Published on ASDNews: Sep 23, 2015


Border Security Conference

Feb 15 - 16, 2017 - Rome, Italy

Register More info

US Export Controls Awareness Tool Kit

Jan 1 - Dec 31, 2016 - Microsoft PowerPoint, Word, Excel and Adobe PDF, Your Computer

Register More info

© 2004-2016 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs